Madan Renu, Dracham Chinna Babu, Khosla Divya, Goyal Shikha, Yadav Arun Kumar
Department of Radiotherapy and Oncology, Postgraduate Institute of Medical Education and Research (PGIMER), Chandigarh, India.
Department of Radiation Oncology, Queen's NRI Hospital, Visakhapatnam, India.
Radiat Oncol J. 2020 Dec;38(4):217-225. doi: 10.3857/roj.2020.00332. Epub 2020 Aug 26.
Erectile dysfunction (ED) is one of the major but underreported concerns in cancer patients and survivors. It can lead to depression, lack of intimacy between the couple, and impaired quality of life. The causes of erectile dysfunction are psychological distress and endocrinal dysfunction caused by cancer itself or side effect of anticancer treatment like surgery, radiotherapy, chemotherapy and hormonal therapy. The degree of ED depends on age, pre-cancer or pre-treatment potency level, comorbidities, type of cancer and its treatment. Treatment options available for ED are various pharmacotherapies, mechanical devices, penile implants, or reconstructive surgeries. A complete evaluation of sexual functioning should be done prior to starting anticancer therapy. Management should be individualized and couple counseling should be an integral part of the anticancer treatment.
勃起功能障碍(ED)是癌症患者及其幸存者面临的主要问题之一,但报告不足。它会导致抑郁、夫妻间亲密关系缺失以及生活质量受损。勃起功能障碍的病因包括心理困扰以及由癌症本身或手术、放疗、化疗和激素治疗等抗癌治疗的副作用引起的内分泌功能障碍。勃起功能障碍的程度取决于年龄、癌症前或治疗前的性功能水平、合并症、癌症类型及其治疗方式。勃起功能障碍的治疗选择包括各种药物治疗、机械装置、阴茎植入物或重建手术。在开始抗癌治疗之前,应对性功能进行全面评估。治疗应个体化,夫妻咨询应成为抗癌治疗不可或缺的一部分。